Geltor 通过改进生产和新的合作伙伴关系，将生物工程胶原蛋白推进到临床前测试。 Geltor advances bioengineered collagen to preclinical testing with improved production and new partnerships.

Agronomics Limited报告说,Geltor公司是一家以可持续蛋白质生产为重点的生物技术公司,在其发展管道中取得了重要里程碑,包括将下一代生物工程科朗推进到临床前测试。 Agronomics Limited reports that Geltor, Inc., a biotechnology company focused on sustainable protein production, has achieved key milestones in its development pipeline, including advancing its next-generation bioengineered collagen into preclinical testing. 最新情况重点介绍了在扩大生产流程和确保建立新伙伴关系以支持商业化努力方面取得的进展。 The update highlights progress in scaling production processes and securing new partnerships to support commercialization efforts. 未披露任何财务细节。 No financial details were disclosed.